Japanese Encephalitis
"Immunogenicity of Live Attenuated SA14-14-2 Japanese Encephalitis Vaccine - A Comparison of 1- and 3-Month Immunization Schedules."
Published in Medical Letter on the CDC and FDA, March 16th, 1998
According to the authors' abstract of an article published in Journal of Infectious Diseases, "Live attenuated SA14-14-2 Japanese encephalitis (JE) vaccine has been safe and effective in >100 million immunized children, but its current administration schedule of two doses given a year apart does not lend itself to inclusion in established Expanded Program of Immunization (EPI) schedules of childhood immunization. Immune responses to immunization at shorter intervals were compared in middle-school-aged children immunized with two doses separated by 1 month (n = 116) or 2.5 months (n = 115), Two vaccine lots were compared. Seroconversion to the vaccine was observed in 100% of vaccinees...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Conference Coverage (Retrovirus)
Unprotected Sex Common Among Men With AIDS - Conference Coverage (DHI Summit)
CDC Researcher Calls for Routine HAV Vaccination of Infants - Outbreak Investigation
Super-Virulent TB Strain May Hold Key to Vaccine - Cardiovascular Disease (Conference News)
Secondary Prevention of Coronary Heart Disease Compared By Type of Insurance - Disease Surveillance
PAHO Official Briefs U.S. Senate on Threat of Infectious Diseases - Drug Warning (Accutane)
Warning About Suicide to go on Acne Medicine - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
